COLL
COLL
US19459J1043
Collegium Pharmaceutical, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
719.15M EUR
1.18B EUR
1.07B EUR
1.47B EUR
Enterprise Value
1.81B EUR
2.14B EUR
1.61B EUR
2.05B EUR
Valuation Multiples
Trailing P/E
17.39x
24.55x
14.3x
24.28x
Forward P/E
3.33x
--
--
--
Price to Sales
0.89x
1.46x
1.35x
2.44x
Price to Book
2.3x
3.77x
3.43x
4.87x
EV/Revenue
2.24x
2.65x
2.02x
3.4x
EV/EBITDA
4.46x
5.31x
3.78x
6.1x
Price to FCF (P/FCF)
2.22x
3.58x
3.25x
5.38x
EV/FCF
5.58x
6.53x
4.88x
7.52x
FCF Yield
45.06%
27.9%
30.78%
18.59%
ende